Cramer’s lightning round: There are better drug stocks to own than GlaxoSmithKline

Cramer’s lightning round: There are better drug stocks to own than GlaxoSmithKline

GlaxoSmithKline PLC: “We don’t care where a stock’s been, we care where it’s going, but it is at $37. It’s got a 5 percent yield. [CEO] Emma Walmsley is supposed to be doing a good job. I have not seen what I’d like to see from that company. As far as I’m concerned, there are much better drug stocks to own than Glaxo.” SiteOne Landscape Supply Inc.: “No. You don’t want to be there because people don’t like housing right now and it’s going to be affiliated with the housing…

Read More

Cramer’s lightning round: I’m not a fan of Netflix’s stock as an end-of-year buy

Cramer’s lightning round: I’m not a fan of Netflix’s stock as an end-of-year buy

Netflix Inc.: “Candidly, I’m not a fan of Netflix. I’m not a fan of Netflix because I think that a lot of it depends on the content and I just don’t find the content as compelling as it once was. I think it’s a good story, but not a great story, because it’s up so much for the year and that’s been a real big determinant about how stocks are doing right now.” Cytokinetics Inc.: “Very speculative, but I’ll endorse it as long as you understand that that thing is…

Read More